FDA Inspection 969787 — Nuvasive PR, Inc.
The FDA completed an inspection of Nuvasive PR, Inc. on February 10, 2016 in Guaynabo, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 10, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Guaynabo, PR (United States)